Designing a broad-spectrum integrative approach for cancer prevention and treatment
Targeted therapies and the consequent adoption of “personalized” oncology have achieved notable successes in some cancers; however, significant problems remain with this approach. Many targeted therapies are highly toxic, costs are extremely high, and most patients experience relapse after a few dis...
Main Author: | Vander Heiden, Matthew G. |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biology |
Format: | Article |
Language: | en_US |
Published: |
Elsevier
2016
|
Online Access: | http://hdl.handle.net/1721.1/105834 https://orcid.org/0000-0002-6702-4192 |
Similar Items
-
Report to the President for year ended June 30, 2023, Koch Institute for Integrative Cancer Research at MIT
by: Vander Heiden, Matthew
Published: (2024) -
Designer broad-spectrum polyimidazolium antibiotics
by: Zhong, Wenbin, et al.
Published: (2021) -
POSACONAZOLE — NEW AZOLE BROAD-SPECTRUM ANTIFUNGAL AGENT FOR PREVENTION AND TREATMENT OF INVASIVE MYCOSES
by: N.N. Klimko
Published: (2008-04-01) -
POSACONAZOLE — NEW AZOLE BROAD-SPECTRUM ANTIFUNGAL AGENT FOR PREVENTION AND TREATMENT OF INVASIVE MYCOSES
by: N.N. Klimko
Published: (2008-01-01) -
Targeting cancer metabolism: a therapeutic window opens
by: Vander Heiden, Matthew G.
Published: (2013)